Latest News for: ocular

Edit

Notice of Proposed Sale of Securities (Form 144) (Ocular Therapeutix Inc)

Public Technologies 12 Feb 2026
). The text version of this document is not available ... Ocular Therapeutix Inc.
Edit

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Ocular Therapeutix Inc)

Public Technologies 06 Feb 2026
The awards were made as an inducement material to each recipient's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4) ... About Ocular Therapeutix, Inc.
Edit

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nasdaq Globe Newswire 06 Feb 2026
... Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Edit

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Nasdaq Globe Newswire 05 Feb 2026
SOL-1 Phase 3 superiority trial results remain masked to date ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Ocular Therapeutix Inc)

Public Technologies 05 Feb 2026
) FORM 4 ... Form 4 or Form 5 obligations may continue ... 2 ... OCULAR THERAPEUTIX, INC [OCUL] 5 ... C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE 3 ... C/O OCULAR THERAPEUTIX, INC ... (1) Represents shares of common stock of Ocular Therapeutix, Inc ... Ocular Therapeutix Inc.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Ocular Therapeutix Inc)

Public Technologies 05 Feb 2026
OCULAR THERAPEUTIX, INC ... Ocular Therapeutix, Inc ... OCULAR THERAPEUTIX, INC ... We, the undersigned officers and directors of Ocular Therapeutix, Inc., hereby severally constitute and appoint Pravin U ... Ocular Therapeutix Inc.
Edit

Ocular Therapeutix (NASDAQ:OCUL) Misses Q4 CY2025 Revenue Estimates

The Call 05 Feb 2026
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ ... Is now the time to buy Ocular Therapeutix? Find out by accessing our full research report, it’s free. Ocular Therapeutix (OCUL) Q4 CY2025 Highlights..
Edit

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights (Form 8-K) (Ocular Therapeutix Inc)

Public Technologies 05 Feb 2026
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights ... Ocular plans to submit NDA for AXPAXLI™ in wet AMD based on SOL-1 52 Week data, pending positive results and planned FDA interactions.
Edit

Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Ocular Therapeutix Inc)

Public Technologies 05 Feb 2026
DEXTENZA for post-surgical ocular inflammation and pain ... DEXTENZA for ocular itching associated with allergic conjunctivitis ... In November 2018, the FDA approved DEXTENZA for the treatment of ocular pain following ophthalmic surgery.
Edit

Precision Ocular Network is new name for Miracles in Sight

Image Winston-Salem Journal 28 Jan 2026
Miracles in Sight, one of the world's largest eye banks, is now Precision Ocular Network as part of a recent merger with Advancing Sight Network ... .
Edit

Following Merger, Advancing Sight Network and Miracles In Sight Become Precision Ocular Network

Business Wire 27 Jan 2026
& CLEMMONS, N.C.--(BUSINESS WIRE)--Advancing Sight Network and Miracles In Sight today announced ...
Edit

Initial Statement of Beneficial Ownership (Form 3) (Ocular Therapeutix Inc)

Public Technologies 27 Jan 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104 ... 0.5 ... Robinson David Wayne ... OCULAR THERAPEUTIX, INC [OCUL] ... C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE 4 ... C/O OCULAR THERAPEUTIX, INC ... Ocular Therapeutix Inc.
Edit

Management Change/Compensation (Form 8-K) (Ocular Therapeutix Inc)

Public Technologies 26 Jan 2026
) ... Effective as of January 20, 2026, Donald Notman, Chief Financial Officer and Chief Operating Officer (principal financial officer and principal accounting officer) of Ocular Therapeutix, Inc ... Notman's anticipated return. Mr ... Mr ... Ocular Therapeutix Inc.
Edit

New autonomous robot outperforms human surgeons in ocular precision

The News International 23 Jan 2026
New autonomous robot outperforms human surgeons in ocular precision ... Robotics by Chinese researchers, a new autonomous robotic system significantly outperforms human surgeons in ocular precision.
Edit

BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound ...

Image The Galveston Daily News 22 Jan 2026
BioTissue Deepens Commitment to Ocular Market Leadership ....

Article Search

tools
×
×
×
×